Prognostic and Predictive Molecular Markers in DCIS-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic and Predictive Molecular Markers in DCIS

Published:2005-09 Issue:5 Volume:12 Page:256-264
ISSN:1072-4109
Container-title:Advances in Anatomic Pathology
language:en
Short-container-title:

Author:

Nofech-Mozes Sharon,Spayne Jacqueline,Rakovitch Eileen,Hanna Wedad

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Anatomy

Reference117 articles.

1. Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS.;Bijker;Eur J Surg Oncol,2001

2. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer.;Fisher;N Engl J Med,1985

3. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial.;Houghton;Lancet,2003

4. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.;Julien;Lancet,2000

5. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.;Fisher;J Clin Oncol,1998

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance;Signal Transduction and Targeted Therapy;2024-04-03

2. Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?;Current Oncology;2023-06-13

3. Risk factors for breast cancer mortality after ductal carcinoma in situ diagnosis differ from those for invasive recurrence;Surgery;2023-02

4. Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent;Breast Cancer Research;2021-02-17

5. Breast ductal Carcinoma in situ associated with microinvasion induces immunological response and predicts ipsilateral invasive recurrence;Virchows Archiv;2020-11-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3